Table 2. The distribution of bronchiectasis patients, number of all-cause and respiratory-cause deaths, and number of hospital admissions in different severity groups stratified by FACED and/or BSI.
| Study/year | Country | Scales | Mild | Moderate | Severe | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total | All-cause mortality | Respiratory-cause mortality | Hospitalizations | Total | All-cause mortality | Respiratory-cause mortality | Hospitalizations | Total | All-cause mortality | Respiratory-cause mortality | Hospitalizations | |||
| Martínez-García/2014a | Spain | FACED | 234 | 10 | 2 | NA | 99 | 25 | 15 | NA | 64 | 44 | 33 | NA |
| Miguel/2014b | Spain | FACED | 249 | 14 | 6 | NA | 105 | 23 | 14 | NA | 68 | 38 | 31 | NA |
| Chalmers/2014 | U.K. | BSI | 191 | 4 | NA | 13 | 224 | 13 | NA | 31 | 193 | 44 | NA | 145 |
| Ellis/2016 | U.K. | FACED | 49 | 8 | NA | NA | 19 | 13 | NA | NA | 6 | 5 | NA | NA |
| BSI | 19 | 4 | NA | NA | 32 | 9 | NA | NA | 23 | 13 | NA | NA | ||
| McDonnell/2016a | Dundee, U.K. | BSI | 136 | 1 | NA | 3 | 211 | 13 | NA | 24 | 147 | 28 | NA | 75 |
| FACED | 303 | 12 | NA | 44 | 145 | 15 | NA | 45 | 46 | 15 | NA | 13 | ||
| McDonnell/2016b | Newcastle, England | BSI | 21 | 0 | NA | 0 | 25 | 1 | NA | 5 | 80 | 15 | NA | 52 |
| FACED | 91 | 6 | NA | 37 | 27 | 7 | NA | 15 | 8 | 3 | NA | 5 | ||
| McDonnell/2016c | Leuven, Belgium | BSI | 51 | 2 | NA | 6 | 63 | 16 | NA | 18 | 76 | 26 | NA | 34 |
| FACED | 100 | 9 | NA | 23 | 65 | 19 | NA | 22 | 25 | 16 | NA | 13 | ||
| McDonnell/2016d | Monza, Italy | BSI | 67 | 0 | NA | 10 | 104 | 3 | NA | 27 | 79 | 11 | NA | 55 |
| FACED | 135 | 3 | NA | 40 | 88 | 4 | NA | 34 | 27 | 7 | NA | 18 | ||
| McDonnell/2016e | Galway, Ireland | BSI | 109 | 8 | NA | 2 | 92 | 11 | NA | 6 | 79 | 25 | NA | 30 |
| FACED | 217 | 23 | NA | 18 | 53 | 19 | NA | 15 | 10 | 2 | NA | 5 | ||
| McDonnell/2016f | Athens, Greece | BSI | 36 | 0 | NA | 1 | 43 | 0 | NA | 7 | 80 | 9 | NA | 27 |
| FACED | 104 | 0 | NA | 17 | 35 | 4 | NA | 9 | 20 | 5 | NA | 9 | ||
| McDonnell/2016g | Vojvodina, Serbia | BSI | 41 | 0 | NA | 0 | 48 | 12 | NA | 8 | 24 | 8 | NA | 12 |
| FACED | 60 | 4 | NA | 2 | 44 | 13 | NA | 3 | 9 | 3 | NA | 1 | ||
| Athanazio/2017 | Latin America | FACED | 350 | 13 | 7 | 4 | 231 | 48 | 29 | 33 | 70 | 34 | 27 | 19 |
| Sim/2017 | Singapore | BSI | 9 | 2 | NA | NA | 19 | 3 | NA | NA | 68 | 36 | NA | NA |
| FACED | 35 | 11 | NA | NA | 40 | 21 | NA | NA | 21 | 9 | NA | NA | ||
| Wang/2018 | China | BSI | 46 | 1 | NA | 15 | 244 | 5 | NA | 57 | 306 | 36 | NA | 105 |
| FACED | 441 | 17 | NA | 123 | 136 | 19 | NA | 48 | 19 | 6 | NA | 6 | ||
| Rosales-Mayor/2017 | Spain | BSI | 36 | NA | NA | NA | 47 | NA | NA | NA | 99 | NA | NA | NA |
| FACED | 108 | NA | NA | NA | 61 | NA | NA | NA | 13 | NA | NA | NA | ||
| Costa/2018 | Portugal | BSI | 13 | NA | NA | NA | 13 | NA | NA | NA | 14 | NA | NA | NA |
| FACED | 20 | NA | NA | NA | 15 | NA | NA | NA | 5 | NA | NA | NA | ||
| Minov/2015 | Macedonia | BSI | 16 | NA | NA | NA | 14 | NA | NA | NA | 7 | NA | NA | NA |
| FACED | 17 | NA | NA | NA | 14 | NA | NA | NA | 6 | NA | NA | NA | ||
Abbreviation: NA, not available.
a, b, c etc means different cohorts in one study.